TScan Therapeutics Announces $100 Million Series C Financing | Company & Finance
WALTHAM, Mass.--(Business enterprise WIRE)--Jan 25, 2021--TScan Therapeutics, a biopharmaceutical corporation targeted on the advancement of T-mobile receptor (TCR) engineered T...